CG
NTRP

Cutler Group’s Neurotrope, Inc. Common NTRP Stock Holding History

Cutler Group’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,200
Closed -$2K – 5806
2020
Q3 		$2K Buy
2,200
+500
+29% +$575 ﹤0.01% 4208
2020
Q2 		$1K Sell
1,700
-1,900
-53% -$2.38K ﹤0.01% 4264
2020
Q1 		$2K Buy
3,600
+1,500
+71% +$1.64K ﹤0.01% 3620
2019
Q4 		$2K Sell
2,100
-2,570
-55% -$2K ﹤0.01% 3569
2019
Q3 		$3K Sell
4,670
-2,129
-31% -$9.76K ﹤0.01% 3406
2019
Q2 		$54K Buy
6,799
+5,399
+386% +$36.3K 0.01% 1498
2019
Q1 		$7K Buy
+1,400
New +$6.02K ﹤0.01% 2761
2018
Q3 		– Sell
-100
Closed – – 4977
2018
Q2 		$0 Sell
100
-400
-80% -$3.68K ﹤0.01% 5195
2018
Q1 		$4K Sell
500
-3,019
-86% -$24K ﹤0.01% 3487
2017
Q4 		$24K Sell
3,519
-534
-13% -$3.11K ﹤0.01% 2423
2017
Q3 		$20K Buy
4,053
+1,950
+93% +$10.2K ﹤0.01% 3160
2017
Q2 		$19K Buy
+2,103
New +$22.5K ﹤0.01% 3484

Other funds holding NTRP

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Cutler Group's NTRP Position: Q4 2020 in Review

Cutler Group sold out of Neurotrope, Inc. Common (NTRP) in Q4 2020, closing a stake of 2,200 shares — an estimated $2K sold.

Cutler Group first reported a position in NTRP in Q2 2017 and held it in 12 quarters. The position peaked at $54K in Q2 2019. 1 fund tracked by Wall St. Rank holds NTRP as of Q4 2020.

  • Cutler Group reported no remaining Neurotrope, Inc. Common position as of Q4 2020 after selling out during the quarter.
  • Cutler Group sold 2,200 Neurotrope, Inc. Common shares in Q4 2020, an estimated $2K.
  • Cutler Group first reported a position in Neurotrope, Inc. Common in Q2 2017 and held it in 12 quarters.
  • Cutler Group's Neurotrope, Inc. Common position peaked at $54K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2020.

Based on Cutler Group's 13F filing for Q4 2020, filed 21 Jan 2021.